What is BioSig Technologies, Inc.'s contact information?

BioSig Technologies, Inc.'s contact information: 1 (469) 633-0101, +12034095444.

How many employees does BioSig Technologies, Inc. have?

BioSig Technologies, Inc. has 5 employees.

What industry does BioSig Technologies, Inc. belong to?

BioSig Technologies, Inc. is in the industry of: Financial Services, Information Technology & Services, Mining & Metals, Medical Devices.

What are BioSig Technologies, Inc.'s official social media profiles?

BioSig Technologies, Inc. Linkedin Page BioSig Technologies, Inc. X Page BioSig Technologies, Inc. Twitter Page

What tech stack does BioSig Technologies, Inc. use?

Some of the popular technologies that BioSig Technologies, Inc. uses are: Linkedin Ads, Outbrain, Facebook Pixel, Google Analytics, Linkedin Insight Tag, Amazon S3.

What are BioSig Technologies, Inc.'s office addresses?

BioSig Technologies, Inc. has 4 known office addresses: 2901 N. Dallas Parkway, Suite 380, Plano, TX 75093, United States 54 Wilton Rd Westport, Connecticut 06880, US 12424 Wilshire Blvd Suite 745 Los Angeles, CA 90025, US 54 Wilton Rd, Westport, Connecticut 06880, Us.

What is BioSig Technologies, Inc.'s open headcount?

BioSig Technologies, Inc. has no job postings yet.

What is the number of ad campaigns for BioSig Technologies, Inc.?

BioSig Technologies, Inc. has no advertisements yet.

What is the number of recent news articles about BioSig Technologies, Inc.?

BioSig Technologies, Inc. has 3 news articles.

BioSig Technologies, Inc. - Pubrio Company Profile & Intent

BioSig Technologies, Inc.

United States · Medical Devices

Financial Services

Information Technology & Services

Mining & Metals

Medical Devices

BioSig Technologies, Inc. is a medical technology company based in Los Angeles, California. It specializes in advanced biomedical signal processing to enhance the visualization and interpretation of cardiac electrical signals. The company focuses on improving electrophysiology (EP) procedures, particularly for diagnosing and treating arrhythmias. BioSig's proprietary signal processing platform addresses challenges in intracardiac signal visualization, aiming to reduce signal noise and improve diagnostic clarity. This technology is designed for electrophysiologists and healthcare providers involved in complex cardiac procedures, with applications in hospitals and specialized EP labs. The company operates in the healthcare sector and targets the growing $8 billion EP market, which is expected to double by 2028.